Millions in funding for development of influenza drugs
Hiroki Kato - For a new approach in the therapy of influenza, Hiroki Kato of the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 of the University of Bonn receives a grant of 2.2 million US dollars from Open Philanthropy.
How can the propagation of influenza viruses be stopped? For a new approach in the therapy of influenza infections, Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 of the University of Bonn receives an Open Philanthropy grant of 2.2 million US dollars. Together with his team, he found a compound that inhibits the body’s own methyltransferase MTr1 and thus prevents the replication of influenza viruses. ...UM DIESEN ARTIKEL ZU LESEN, ERSTELLEN SIE IHR KONTO
Und verlängern Sie Ihre Lektüre, kostenlos und unverbindlich.
